THE IMPACT OF DIGITAL TECHNOLOGIES ON THE PHARMACEUTICAL INDUSTRY

Аннотация

The pharmaceutical industry, a critical component of global healthcare, is undergoing a transformative shift driven by digital technologies. This article explores how advancements such as Artificial Intelligence (AI), Big Data, the Internet of Things (IoT), and blockchain are revolutionizing various facets of the industry. From accelerating drug discovery and development through predictive analytics and personalized medicine to enhancing manufacturing processes and supply chain management with smart technologies and automation, digital innovations are reshaping the landscape. The integration of digital platforms in drug distribution and patient care, including telemedicine and mobile health applications, is improving access and adherence to treatment. However, the rapid evolution of these technologies also presents regulatory and ethical challenges that must be addressed. Keywords: digital technologies, pharmaceutical industry, artificial intelligence (AI), big data, internet of things (IOT), blockchain, drug discovery, personalized medicine, drug manufacturing. The pharmaceutical industry is undergoing a profound transformation, driven by the integration of digital technologies that are reshaping the landscape of drug discovery and development. From artificial intelligence to genomics, these innovations are streamlining processes, enhancing precision, and accelerating the journey from laboratory to market. AI and ML algorithms are revolutionizing the way researchers analyze vast datasets to predict interactions between various compounds and biological targets. By leveraging predictive analytics, scientists can rapidly identify promising drug candidates, significantly shortening the timeline for drug discovery. Another groundbreaking application of AI lies in drug repurposing. Machine learning models can sift through existing drug databases to uncover potential new uses for established medications, thereby reducing both the time and cost associated with developing new therapies. Notable examples include the use of AI in developing treatments for rare diseases and complex conditions like Alzheimer's. In these cases, AI has enabled researchers to identify viable candidates more quickly than traditional methods would allow, showcasing its potential to transform drug discovery 159 ACADEMIC RESEARCH IN MODERN SCIENCE International scientific-online conference timelines. Big Data technologies facilitate the integration of diverse datasets— ranging from genomics to clinical trials and patient records—allowing researchers to uncover insights that were previously inaccessible. This holistic approach optimizes the drug development process and informs decision-making at every stage [1, 1-11]. Advanced analytics play a crucial role in improving clinical trial design and execution. By enhancing patient selection criteria, monitoring processes, and outcome assessments, these technologies lead to more effective trials with higher success rates. The utilization of real-world data post-market enables pharmaceutical companies to assess drug efficacy and safety in diverse populations. This evidence-based approach fosters informed decision-making and helps refine treatment protocols. Digital technologies are essential for analyzing genomic data, allowing researchers to identify genetic markers linked to diseases and responses to drugs. This capability is pivotal in the development of targeted therapies that address specific patient needs. In conclusion, the integration of digital technologies into drug discovery and development is transforming the pharmaceutical industry. By streamlining processes, enhancing precision, and fostering innovation, these advancements are paving the way for more effective treatments and improved patient outcomes. As we continue to harness the power of AI, big data, genomics, and simulation techniques, the future of medicine looks increasingly promising [3, 125-131]. The pharmaceutical industry is witnessing a significant transformation in drug manufacturing and supply chain management, driven by innovative digital technologies. These advancements enhance efficiency, quality, and transparency, ultimately leading to better patient outcomes and more reliable access to medications. IoT devices and sensors are revolutionizing manufacturing processes by enabling real-time monitoring and control. This integration ensures optimal production conditions, reduces variability, and enhances overall operational efficiency. By utilizing IoT systems, manufacturers can predict equipment failures before they occur. This proactive approach minimizes downtime, ensuring a continuous production flow and reducing the risk of delays in drug availability. Real-time quality monitoring facilitated by IoT technology significantly reduces the risk of defects. By ensuring compliance with regulatory standards, manufacturers can maintain high-quality production processes and safeguard patient safety. Blockchain technology provide